We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » High Court Likely to Keep ‘Safe Harbor’ Broad, Boosting Generics, Biosimilars
High Court Likely to Keep ‘Safe Harbor’ Broad, Boosting Generics, Biosimilars
September 11, 2012
The country’s highest court is likely to mull Hatch-Waxman’s safe-harbor provision now that the U.S. Court of Appeals for the Federal Circuit has issued contradictory rulings on when the law allows drugmakers to use others’ patents without fear of infringement.